Impact of COVID-19 Restrictions on Retinal Detachment: A Multicenter Experience.

Jonathan Chang // Publications // Feb 07 2022

PubMed ID: 35144021

Author(s): Jung JJ, Chang JS, Oellers PR, Ali MH, Do BK, Tseng JJ, Roizenblatt R, Muni RH, Weng CY, Oakey ZB, Tsao SW, Rofagha S, Chan X; Young Retina Forum, Hoang QV. Impact of COVID-19 Restrictions on Retinal Detachment: A Multicenter Experience. Ophthalmol Retina. 2022 Feb 7. pii: S2468-6530(22)00046-X. doi: 10.1016/j.oret.2022.02.001. [Epub ahead of print] PMID 35144021

Journal: Ophthalmology. Retina, Feb 2022

In this retrospective multicenter study of 261 eyes (259), patients who underwent rhegmatogenous retinal detachment repair during the coronavirus disease 2019 (COVID-19) post-lockdown period experienced an additional 22-day delay leading to significantly more epiretinal membrane, proliferative vitreoretinopathy and lower single surgery anatomic success. During lockdown, perfluoropropane (C3F8) gas was utilized more commonly; and pneumatic retinopexy was used more commonly in COVID-19-positive patients.

Copyright © 2022 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.